Clinical Trials Browser

Glioblastoma × poly ICLC × 90 days × Clear all

NCT05283109 2026-04-30

ETAPA I

Phase 1 Active not recruiting

24 enrolled 9 charts

Glioblastoma, Glioma

NCT02287428 2026-04-17

Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

Phase 1 Active not recruiting

Glioblastoma